Drug Pipeline and Clinical Trial Results: Positive data from clinical trials or FDA approval of new drugs often drives the stock price upward. Conversely, failures or delays can cause the price to decline.

Financial Performance: Revenue, earnings, and profit margins directly impact investor confidence. Strong financial results generally lead to a higher stock price.

Market Competition: The presence of competing drugs, particularly generics or those offering superior efficacy, can negatively impact Gilead's market share and price.

Regulatory Environment: Changes in healthcare regulations, drug pricing policies, and patent laws can significantly affect Gilead's revenue streams and stock valuation.

Overall Market Conditions: General economic conditions, investor sentiment, and broader market trends (e.g., bull or bear markets) can influence Gilead's stock price, regardless of company-specific factors.

Acquisitions and Partnerships: Strategic acquisitions or partnerships with other biotech companies can boost Gilead's pipeline and market position, positively affecting the stock price.